DERM

Journey Medical Corporation NASDAQ Listed Nov 12, 2021

Healthcare ·Drug Manufacturers - Specialty & Generic ·US · journeymedicalcorp.com

$5.00

Mkt Cap $136.7M

52w Low $4.31 13.2% of range 52w High $9.55

50d MA $6.15 200d MA $7.34

P/E (TTM) -11.0x

EV/EBITDA -43.1x

P/B 4.0x

Debt/Equity 0.0x

ROE -35.9%

P/FCF -15.2x

RSI (14) —

ATR (14) —

Beta 1.04

50d MA $6.15

200d MA $7.34

Avg Volume 205.5K

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

SIC Code

2834

CIK (SEC)

1867066

Phone

480 434 6670

9237 East Via de Ventura Boulevard · Scottsdale, AZ 85258 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 25, 2026	AMC	-0.06	-0.04	+33.3%	6.83	-13.6%	-30.0%	-4.2%	-4.1%	+6.8%	-1.1%	—
Nov 12, 2025	AMC	-0.08	-0.09	-12.5%	9.08	-3.6%	-15.3%	+2.6%	-2.5%	+3.4%	-3.8%	—
Aug 12, 2025	AMC	-0.07	-0.16	-128.6%	8.54	-13.2%	-15.1%	+0.1%	-4.3%	+0.7%	+1.0%	—
May 14, 2025	AMC	-0.24	-0.18	+25.0%	5.97	+4.5%	+18.9%	-2.3%	-2.7%	+1.9%	-1.5%	—
Mar 26, 2025	AMC	-0.22	0.08	+136.4%	6.14	+1.0%	-3.6%	+3.2%	-3.4%	+1.2%	+4.5%	—
Nov 12, 2024	AMC	-0.17	-0.12	+29.4%	5.45	+0.9%	-6.1%	-0.8%	+1.6%	-2.1%	+5.9%	—
Aug 12, 2024	AMC	-0.15	-0.17	-13.3%	4.22	+3.3%	+14.2%	-1.2%	-4.2%	-2.9%	+3.2%	—
May 13, 2024	AMC	-0.26	-0.53	-103.8%	3.57	-3.4%	+1.1%	-0.6%	+0.8%	-4.7%	-1.4%	—
Mar 21, 2024	AMC	-0.08	-0.12	-50.0%	3.82	-8.4%	-13.6%	-11.5%	+26.4%	+5.4%	-5.4%	—
Nov 7, 2023	AMC	-0.15	0.80	+633.3%	3.43	+9.3%	+9.6%	-2.1%	+1.4%	+6.4%	+1.3%	—
Aug 8, 2023	AMC	-0.34	-0.46	-35.3%	2.40	+0.0%	+1.7%	-8.2%	+0.0%	-2.7%	-3.2%	—
May 22, 2023	AMC	-0.44	-0.57	-29.5%	1.42	-2.8%	-12.7%	+0.0%	-10.5%	-4.5%	+8.5%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 26	HC Wainwright & Co.	Maintains	Buy → Buy	—	$6.83	$5.90	-13.6%	-30.0%	-4.2%	-4.1%	+6.8%	-1.1%
Aug 13	Lake Street	Maintains	Buy → Buy	—	$8.54	$7.41	-13.2%	-15.1%	+0.1%	-4.3%	+0.7%	+1.0%
Jul 30	B. Riley Securities	Maintains	Buy → Buy	—	$7.59	$7.64	+0.7%	+0.0%	-3.2%	-4.9%	+2.1%	+1.0%
Sep 7	B. Riley Securities	Maintains	Buy → Buy	—	$2.51	$2.41	-4.0%	+3.6%	+13.5%	-3.1%	-7.0%	-2.3%
Jul 12	B. Riley Securities	Maintains	Buy → Buy	—	$2.36	$2.49	+5.5%	-12.3%	-14.5%	+1.1%	+1.1%	+2.2%
May 23	B. Riley Securities	Maintains	Buy → Buy	—	$1.42	$1.38	-2.8%	-12.7%	+0.0%	-10.5%	-4.5%	+8.5%

Data updated apr 25, 2026 4:57am · Source: massive.com